Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

CorMedix Company Profile (NASDAQ:CRMD)

Consensus Ratings for CorMedix (NASDAQ:CRMD) (?)
Ratings Breakdown: 2 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $2.35 (67.86% upside)

Analysts' Ratings History for CorMedix (NASDAQ:CRMD)
Show:
DateFirmActionRatingPrice TargetDetailsShare
12/8/2014Roth CapitalLower Price TargetBuy$3.00 -> $2.50ViewTweet This Rating  Share This Rating on StockTwits
7/28/2014ZacksDowngradeNeutral$2.20ViewTweet This Rating  Share This Rating on StockTwits
7/24/2014Roth CapitalInitiated CoverageBuy$3.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/19/2012 forward)